Premium
Bosentan and sildenafil: Should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Author(s) -
Brancaccio Gianluca,
Toscano Alessandra,
Bevilacqua Maurizio,
Di Chiara Luca,
Parisi Francesco
Publication year - 2007
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2006.00606.x
Subject(s) - sildenafil , bosentan , medicine , prostacyclin , combination therapy , endothelin receptor , receptor
We report a case of a seven‐yr‐old girl with a PAH treated with continuation therapy of bosentan and sildenafil. The combination therapy revealed safety and efficacy in long‐term follow up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom